Company / R&D per Share
AbCellera Biologics Inc. R&D per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.63
FY2025
5-year range
$0.04 / $0.63
FY2021-FY2025
Trend
+9.8%
vs FY2024
Sector context
#169 of 208
Health Care
What the data says
AbCellera Biologics Inc.'s r&d per share of $0.63 is lower than 81% of companies in the Health Care sector (FY2025). R&D per Share has fluctuated over the past 7 years, ranging from $0.04 in FY2021 to $0.63 in FY2025.
Based on SEC 10-K filings.
0.63 in FY2025 with a 5-year CAGR of +41.4%.
Improved from $0.61 to $0.63 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +82.6%
- 5-Year CAGR
- +41.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 208This company $0.63 Sector average $12.19
▼
-94.8% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 9.8% year-over-year.
- Ranks #169 out of 208 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.63 | +9.8% |
| FY2024 | $0.58 | -6.1% |
| FY2023 | $0.61 | +490.1% |
| FY2022 | $0.10 | +176.5% |
| FY2021 | $0.04 | -66.4% |
| FY2020 | $0.11 | +67.2% |
| FY2019 | $0.07 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026